Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

746.0500 21.20 (2.92%)

NSE Jul 01, 2025 15:57 PM

New 52W High today

Volume: 4.7M

High volume today

Laurus Labs Ltd.

28 Jul 2022

746.05

2.92%

Laurus Labs (BUY): Synthesis business saves the day

Buy: Laurus Labs Ltd.

Recommendation

BOB Capital Markets Ltd.

Q1 revenue/EBITDA came in 5%/8% above consensus and grew 20%/ 15% YoY to Rs 15.4bn/Rs 4.5bn

Laurus Labs Ltd. is trading at high day volume of 4.7M.